Bacillus subtilis, selective breeding method therefor and use thereof

By breeding Bacillus subtilis with strong sulforin degradation ability, microbial fermentation method efficiently degrades sulforin in rapeseed meal, solving the problem of anti-nutritional factors in rapeseed meal, improving the nutrient content and ensuring biosafety , suitable for large-scale feed applications.

WO2025007626A1PCT designated stage expired Publication Date: 2025-01-09PEARL RIVER FISHERY RES INST CHINESE ACAD OF FISHERY SCI

Patent Information

Application Number
PCT/CN2024/090379
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-07-05
Filing Date
2024-04-28
Publication Date
2025-01-09

AI Technical Summary

Technical Problem

The presence of anti-nutrition factor glucoside and other substances in rapeseed meals has limited use in feeds. The existing detoxification methods are costly and unsatisfactory, and chemical detoxification poses a risk of environmental pollution, making it difficult to apply on a large scale.

Method used

Breeding of Bacillus subtilis has strong sulfosinolytic degradation ability, and efficiently degrades sulfosinolytics in rapeseed meal through microbial fermentation and detoxification method, improves nutrient content, and meets the safety requirements of fermented feed strains.

Benefits of technology

It has achieved efficient degradation of sulforin in rapeseed meal, increased the nutrient content of rapeseed meal, and the application of this strain is highly biosafe, suitable for large-scale feed fermentation, and avoided the risk of environmental pollution caused by chemical detoxification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2024090379-FTAPPB-I100001
    Figure PCTCN2024090379-FTAPPB-I100001
  • Figure PCTCN2024090379-FTAPPB-I100002
    Figure PCTCN2024090379-FTAPPB-I100002
  • Figure PCTCN2024090379-FTAPPB-I100003
    Figure PCTCN2024090379-FTAPPB-I100003
Patent Text Reader

Abstract

The present invention relates to the field of biologicals, and relates to Bacillus subtilis, a selective breeding method therefor and a use thereof. The preservation number of the Bacillus subtilis is GDMCC No: 62938, and the preservation organization of the Bacillus subtilis is the Guangdong Microbial Culture Collection Center. The Bacillus subtilis has a strong glucosinolate degradation capacity, and can effectively degrade glucosinolates in rapeseed meal and increase the content of nutrients in the rapeseed meal; in addition, the Bacillus subtilis meets safety requirements for fermentation strains in the Guidelines on Identification and Safety Evaluation of Direct-fed Microbials and Fermented-Food-Derived Bacterial Strains.
Need to check novelty before this filing date? Find Prior Art

Description

Bacillus subtilis, breeding method and application thereof Technical Field

[0001] The present invention relates to the field of biological products, in particular to a Bacillus subtilis and a breeding method and application thereof. Background Art

[0002] Rapeseed meal (MR) is a by-product of rapeseed oil extraction. It has a protein content of about 36% and is the second largest plant protein raw material in aquatic feed. Against the backdrop of the "soybean meal reduction and substitution campaign", rapeseed meal has shown great development potential. However, rapeseed meal also contains a variety of anti-nutritional factors, such as glucosinolates GS (short for glucosinolates, with a molecular formula of C 12 H 23 NO 10 S3), tannins (Tannin tannic acid) and phytic acid (Phytic acid), among which glucosinolates are the most harmful to animals. Excessive intake by animals will damage the animal's thyroid gland, leading to growth stunting and even death, which greatly limits the use of rapeseed meal in feed. The utilization rate of rapeseed meal can be improved through detoxification. Currently known detoxification methods mainly include physical detoxification, chemical detoxification and microbial fermentation detoxification. However, physical and chemical detoxification methods have obvious disadvantages. First, the cost is high and the removal effect is not ideal; second, the chemical solvents used in chemical detoxification can only remove a single substance, and the detoxification process often loses sight of one thing while focusing on another; third, the use of chemical reagents has certain risks, and the wastewater from chemical treatment will pollute the environment; fourth, the detoxification method is difficult to use on a large scale. Therefore, it is necessary to study the problem of rapeseed meal detoxification.

[0003] Summary of the Invention

[0004] In response to the above problems, the present invention provides a Bacillus subtilis, which has a strong glucosinolate degradation ability, can efficiently degrade glucosinolates in rapeseed meal, and increase the content of nutrients in rapeseed meal. In addition, the Bacillus subtilis meets the national safety requirements for fermentation feed strains.

[0005] In order to achieve the above object, the present invention provides a Bacillus subtilis, the preservation number of the Bacillus subtilis is GDMCC No: 62938, and the preservation institution is Guangdong Provincial Microbial Culture Collection Center.

[0006] During the research process on the above-mentioned rapeseed meal detoxification problem, the inventors found that compared with physical detoxification and chemical detoxification methods, microbial fermentation detoxification is currently the safest and most effective detoxification method. Its principle is that microorganisms use rapeseed meal as a carbon source and nitrogen source for growth nutrition to metabolize and produce extracellular enzymes, which degrade the glucosinolates in the rapeseed meal. The microorganisms used for feed fermentation mainly include lactic acid bacteria, yeasts, molds and Bacillus, among which Bacillus is widely distributed in nature. Because of its strong survival ability and ability to produce extracellular enzymes, it is also often used as a probiotic in aquaculture. Bacillus subtilis has become one of the most common bacterial species in the feed fermentation process due to its high safety. However, conventional Bacillus subtilis has an unsatisfactory ability to degrade glucosinolates. Therefore, the inventors selected and bred the aforementioned Bacillus subtilis, which has a strong ability to degrade glucosinolates and can efficiently degrade glucosinolates in rapeseed meal, thereby increasing the nutrient content of the rapeseed meal. Furthermore, the Bacillus subtilis meets the safety requirements for fermentation strains as specified in the "Guidelines for the Identification and Safety Assessment of Strains for Direct-Fed Microorganisms and Fermentation Product Production."

[0007] In one embodiment, the Bacillus subtilis secretes enzymes for decomposing glucosinolates.

[0008] In one embodiment, the Bacillus subtilis secretes an enzyme for decomposing myrosinase potassium. The inventors have experimentally verified that the Bacillus subtilis can secrete an enzyme with similar functional activity to myrosinase, thereby being able to decompose myrosinase potassium.

[0009] The present invention also provides application of the Bacillus subtilis in feed fermentation.

[0010] The above-mentioned Bacillus subtilis can efficiently degrade glucosinolates, and its genome does not contain known virulence factors of Bacillus such as hblC, bceT, CytK, PlcR and nheA, and no drug resistance has been detected. Therefore, its application in feed fermentation has high biosafety.

[0011] In one embodiment, the feed comprises rapeseed meal.

[0012] The present invention also provides application of the Bacillus subtilis in glucosinolate degradation.

[0013] The present invention also provides a feed comprising detoxified rapeseed meal, wherein the detoxification treatment comprises the following steps: fermenting the rapeseed meal with the Bacillus subtilis.

[0014] The present invention also provides a method for preparing a feed, wherein the raw material of the feed includes rapeseed meal, and the method for preparing the feed includes the following steps: fermenting the rapeseed meal with the Bacillus subtilis.

[0015] The present invention also provides a method for breeding the Bacillus subtilis, comprising the following steps:

[0016] Primary screening: Culture the parent strain, select single colonies, purify and culture to obtain isolated strains, selectively culture with glucosinolates to obtain glucosinolate-utilizing strains, culture to the logarithmic growth phase, and screen for strains without hemolytic rings;

[0017] Rescreening: Add the strain without hemolytic ring to rapeseed meal and perform solid-state fermentation to screen out Bacillus subtilis.

[0018] In one embodiment, the selective culture comprises: applying the isolated strain to a glucosinolate selective culture medium and culturing at 35-40° C. for 20-30 hours;

[0019] The screening to obtain the strain without hemolytic ring comprises: inoculating the glucosinolate utilizing strain cultured to the logarithmic growth phase onto a blood plate, and culturing at 35-40° C. for 20-30 hours.

[0020] The material-liquid ratio of the solid-state fermentation is (6-8):2, the temperature of the solid-state fermentation is 22-27° C., and the time of the solid-state fermentation is 45-50 hours.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The present invention discloses a Bacillus subtilis strain, a breeding method, and applications thereof. The Bacillus subtilis strain has a strong glucosinolate degradation ability and can efficiently degrade glucosinolates in rapeseed meal, thereby increasing the nutrient content of the rapeseed meal. The Bacillus subtilis strain also meets the safety requirements for fermentation strains specified in the "Guidelines for the Identification and Safety Assessment of Strains for Direct-Fed Microorganisms and Fermentation Product Production." The Bacillus subtilis strain is capable of efficiently degrading glucosinolates, does not contain known virulence factors of Bacillus, such as hblC, bceT, CytK, PlcR, and nheA, in its genome, and has not been detected to harbor drug resistance. Therefore, the Bacillus subtilis strain exhibits high biosafety when used in feed fermentation. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 is a graph showing the results of screening for hemolytic activity of strains, where A is 2YB4, B is 10XH1, and C is 3YB5.

[0024] Figure 2 is a graph showing the results of screening for hemolytic activity of strains, where D represents BL35, E represents JD1, and F represents BSY82.

[0025] FIG3 is a graph showing the results of screening the hemolytic activity of the strains, where G is 8YB5 and H is 8YB4.

[0026] FIG4 is a diagram showing the plate culture results of BSY82 colonies.

[0027] FIG5 is a diagram showing the Gram staining results of BSY82 colonies.

[0028] FIG6 is a bacterial morphology diagram of the BSY82 colony.

[0029] Figure 7 is a phylogenetic tree constructed based on 16S rRNA.

[0030] Figure 8 is a phylogenetic tree constructed based on the rpoB gene.

[0031] FIG9 is a graph showing the hydrophilicity / hydrophobicity analysis results of the protein encoded by the BglA gene.

[0032] FIG10 is a diagram showing the prediction results of the signal peptide of the protein encoded by the BglA gene.

[0033] FIG11 is a diagram showing the predicted results of the transmembrane region of the protein encoded by the BglA gene.

[0034] FIG12 is a diagram showing the tertiary structure prediction results of the protein encoded by the BglA gene.

[0035] FIG13 is a standard curve of glucose content after strain BSY82 was inoculated into LB liquid medium for culture.

[0036] FIG14 is a graph showing the retention time of the myrosinase standard on the chromatographic column, wherein the peak value is 5.293.

[0037] FIG15 is a graph showing the retention time of the fermentation broth on the chromatographic column, wherein the peak value is 5.220. DETAILED DESCRIPTION

[0038] To facilitate understanding of the present invention, the present invention will be described more fully below with reference to the accompanying drawings. Preferred embodiments of the present invention are shown in the accompanying drawings. However, the present invention may be implemented in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided to provide a more thorough and comprehensive understanding of the present disclosure.

[0039] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in this specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0040] source:

[0041] Grass carp and zebrafish (from the breeding base of the Pearl River Fisheries Research Institute), the tested probiotic strains (from the laboratory strain bank of the Pearl River Fisheries Research Institute, Chinese Academy of Fishery Sciences, the strains in this strain bank are mainly derived from the breeding environment, fish intestines, etc.), LB medium (purchased from Guangdong Huankai Microbiology Technology Co., Ltd.), drug sensitivity paper (purchased from Hangzhou Microbiology Reagent Co., Ltd.), palladium chloride (purity 99%, Sangon Biotechnology (Shanghai) Co., Ltd.), sodium carboxymethyl cellulose (McLean), Sinigrin (purchased from Sigma-Aldrich), Bacillus physiological and biochemical reagent strips API 50CHB (bi-oMérieux, France), nitrogen source culture medium (purchased from Beijing Solebold Technology Co., Ltd.), DNS staining solution (purchased from Feijing Biotechnology Co., Ltd.), T6 UV-visible spectrophotometer (purchased from Beijing Puxi General Instrument Co., Ltd.), biochemical incubator (purchased from Shanghai Yiheng Scientific Instrument Co., Ltd.), and high-speed desktop refrigerated centrifuge (purchased from Guangzhou Yice Instrument Co., Ltd.).

[0042] Unless otherwise specified, the reagents, materials, and equipment used in this example are all commercially available; and the experimental methods, unless otherwise specified, are all conventional experimental methods in the art.

[0043] Preservation Instructions:

[0044] Name of biological material and indicated identification characteristics: Bacillus subtilis BSY82 (the direct source of the parent strain of this strain is the laboratory strain bank of the Pearl River Fisheries Research Institute of the Chinese Academy of Fishery Sciences. The original source of this parent strain was isolated from the pond water of a farm in Guangdong in 2020 by the laboratory of the inventor);

[0045] Depository: Guangdong Provincial Microbial Culture Collection Center;

[0046] The registration number of this depository is GDMCC No: 62938;

[0047] The biological material (strain) requested for deposit is accompanied by: Proposed taxonomic name: Bacillus subtilis;

[0048] This biological material (strain) was received by this depository on November 2, 2022 and registered.

[0049] The viability of this biological material (strain) was tested by this depository on November 2, 2022, and the result was that it was viable.

[0050] Example

[0051] 1. Prepare culture medium.

[0052] 1. Preparation of glucosinolate selective culture medium: Add 100 g rapeseed meal to 900 mL of water, boil for 10 min, filter through 8 layers of gauze to collect the filtrate, centrifuge the filtrate at 7500 rpm for 10 min, collect the supernatant and dilute to 1 L as the glucosinolate crude extract.

[0053] Take 100 mL of crude glucosinolate extract, add peptone (10 g), NacL (10 g), and agar (15 g) to make up to 1000 mL, sterilize at 121°C for 20 min, and pour into plates for later use.

[0054] 2. Cellulase qualitative culture medium: Mix 10 g of tryptone, 10 g of yeast extract, 15 g of NaCl, 10 g of sodium carboxymethyl cellulose (CMC-Na), 15 g of agar, and 1000 mL of distilled water, adjust the pH to 7.0, sterilize at 121°C for 15 min, and set aside.

[0055] 3. Protease qualitative culture medium: Solution A: 100 mL of 1.5% skim milk powder, sterilized at 115°C for 15 minutes; Solution B: 100 mL of LB medium, add 3% agar by weight, sterilize at 121°C for 25 minutes, and adjust the pH to 7.0-7.2. Mix Solution A and Solution B, cool to 60°C, and pour into a culture dish. Set aside.

[0056] 2. Breeding methods of Bacillus subtilis.

[0057] 1. Initial screening.

[0058] 192 strains of probiotics in our laboratory were activated and cultured to OD 600 = 0.5, diluted 100-fold and applied to the glucosinolate selective medium prepared in step 1 of this example, cultured at 37°C for 24 hours, screened out strains that can grow in the glucosinolate selective medium, and obtained glucosinolate-utilizing strains. On this basis, the protease and cellulase production abilities of the strains were qualitatively analyzed, and wells were punched in the protease qualitative medium and the cellulase qualitative medium, and 30 μL of activation culture was added to each well until the OD 600 = 0.5 of the bacterial solution, cultured at 37 ° C for 24 hours, the diameter of the hydrolysis zone of the culture medium was measured, and comprehensive screening was performed. The specific criteria for this comprehensive screening are: the value of the strain in each item is divided by the maximum value in the item as the score of the item, and the strain with the highest score is selected by adding the last three items. For example, the score of BL35: glucosinolate degradation rate score: 64.3% ÷ 67% (maximum) = 0.96; protease score: 23.7 ÷ 27.93 (maximum) = 0.85; cellulase score: 13.03 ÷ 19.73 (maximum) = 0.66; total score: 0.96 + 0.85 + 0.66 = 2.47.

[0059] After comprehensive screening, several candidate strains were obtained. After being cultured to the logarithmic growth phase, 10 μL of bacterial solution was spotted on sheep blood agar plates. After being cultured at 37°C for 24 hours, the colonies were observed to see if a hemolytic ring appeared. The results are shown in Figures 1, 2, and 3. Eight strains without a hemolytic ring were screened.

[0060] 2. Rescreen.

[0061] The strains without hemolytic rings obtained in the initial screening were cultured at 37°C for 12 h, and the bacterial solution concentration was adjusted to 1.0×10 7 cfu / mL. The bacterial suspension of each strain was added to rapeseed meal for solid-state fermentation, achieving a solid-liquid ratio of 7:2 (i.e., a rapeseed meal to bacterial suspension mass ratio of 7:2). Fermentation was carried out at room temperature (22-27°C) for 48 hours. The glucosinolate content in the fermented rapeseed meal was determined. Method for determining glucosinolate content: Weigh 100 mg of fermented rapeseed meal into a 10 mL test tube, dry-steam in a boiling water bath for 10 minutes, add 8-10 mL of hot water at approximately 90°C, and steam again in a boiling water bath for 30 minutes, stirring twice. Remove and allow to cool, then dilute to 10 mL with water and shake well. After filtration, transfer 0.5 mL of the solution to another test tube. Add 2 mL of 0.15% sodium carboxymethyl cellulose solution to one tube, mix thoroughly, then add 1 mL of 8 μmol / L PdCl₂ solution, shake well, and incubate at 20°C for 1 hour. Measure the absorbance (E₂) at 540 nm using distilled water instead of the filtrate as a reference. Add 2 mL of 0.15% sodium carboxymethyl cellulose solution to the other tube, followed by 1 mL of 0.03 mol / L HCl. Incubate at room temperature for 1 hour. Measure the absorbance (E₂) using 1 mL of distilled water plus 2 mL of 0.15% sodium carboxymethyl cellulose as a blank control. The absorbance of glucosinolates, E₂, is calculated as E₂ - E₂. Glucosinolate content (μmol / mL) = 0.2 + 185.2 × E₂.

[0062] The experimental results are shown in the table below. The strain with the best comprehensive indicators was screened and named BSY82. In addition, the inventors have deposited the strain in the Guangdong Provincial Microbiological Culture Collection Center (GDMCC) on November 2, 2022, at Building 59, 5th Floor, No. 100 Xianlie Middle Road, Guangzhou, Postal Code: 510070, with the deposit number: GDMCC No: 62938 and the taxonomic name: Bacillus subtilis.

[0063] Table 1 Glucosinolate degradation rate, protease and cellulase hydrolysis circle diameter

[0064] 3. Drug sensitivity test.

[0065] The screened Bacillus subtilis BSY82 was inoculated into liquid culture medium and cultured for 4-6 hours. The concentration of the bacterial solution was determined by OD 600When the absorbance is 0.5, dilute the bacterial solution tenfold and apply it to MH solid medium. After the solution dries, use sterile tweezers to attach a drug-sensitive paper strip to the surface of the medium. Incubate the medium upside down in a 37°C biochemical incubator for 18-20 hours. Measure the diameter of the inhibition zone on each drug-sensitive paper strip. Refer to the drug-sensitive paper strip instructions to determine the drug sensitivity of the strain. The test results are shown in the table below.

[0066] Table 3 Drug sensitivity test results of strain BSY82

[0067] 4. Minimum inhibitory concentration (MIC) experiment.

[0068] Using the two-fold dilution method, first add 50 μL of LB liquid medium to each well of a 96-well plate, then add 50 μL of antibiotics to the first column for gradient dilution. The content of each column of drugs is 256, 128, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25 and 0.125 mg / L. Then inoculate 50 μL of bacterial solution (OD 600 0.5, and then diluted 100 times) to a final concentration of 5 × 10 6 CFU / mL. The positive control group received only the bacterial solution without antibiotics, while the negative control group received only antibiotics. The results are shown in the table below.

[0069] Table 4 Minimum inhibitory concentrations of seven antibiotics against strain BSY82

[0070] 5. Biosafety evaluation.

[0071] Healthy grass carp (30 ± 5 g) and zebrafish (0.2 ± 0.01 g) were selected as experimental fish. Each type of fish was divided into three experimental groups and one control group. The experimental fish were temporarily kept in a fish tank (water temperature was controlled at 28 ° C) for one week before subsequent experiments. Bacillus subtilis BSY82 was prepared into a bacterial solution and inoculated into LB liquid medium at a ratio of 1:100 to make a final concentration of 1.0 × 10 5 -1.0×10 7 cfu / mL, culture at 37℃ with shaking for 4h, centrifuge at 5000r / min for 5min, remove the supernatant, add a small amount of physiological saline to resuspend, and adjust the bacterial solution to 1.5×10 9 cfu / mL, 1.5×10 8 cfu / mL and 1.5×10 7 cfu / mL three concentration gradients, physiological saline as negative control, intraperitoneal injection, grass carp injection volume per tail 100μL, zebrafish injection volume per tail 30μL, the observation period is 7 days, observe and record the feeding and movement of the experimental fish.

[0072] The experimental results showed that during the experimental period, no fish in the experimental group died or showed other abnormal phenomena, indicating that strain BSY82 has good biosafety for grass carp and zebrafish.

[0073] 6. Strain identification.

[0074] 1. Morphological observation.

[0075] The strain BSY82 was inoculated into LB solid medium and cultured in a constant temperature incubator at 37°C for 24 h. The shape, size and color of the colonies and bacteria were observed.

[0076] The results are shown in Figures 4, 5 and 6. The colony morphology is round or oval, with wrinkled surface, irregular edges, upward bulge and opaque. Microscopic observation revealed that the bacteria are short rod-shaped positive bacteria with a length of about 2 μm. They can produce spores with a spore rate of 85%.

[0077] 2. Physiological and biochemical identification.

[0078] The morphology of the strains was observed by Gram staining, and the biochemical parameters of the strains were identified using Bacillus physiological and biochemical reagent strips API 50CHB (bi-oMérieux, France) and nitrogen source culture medium (Solarbio).

[0079] The results are shown in the table below. The strain BSY82 can use D-arabinose, ribose, glucose, fructose and other carbohydrates as carbon sources for growth. It can use beef extract, peptone and yeast powder as organic nitrogen sources, and ammonium sulfate, ammonium chloride, ammonium citrate and diammonium hydrogen phosphate as inorganic nitrogen sources. The oxidase test was negative and the catalase test was positive. The physiological and biochemical indicators were similar to those of Bacillus subtilis.

[0080] Table 5 Physiological and biochemical identification results of strain BSY82

[0081] 3. Molecular biology identification.

[0082] Genomic DNA from strain BSY82 was extracted according to the instructions of the BIOMIGA DNA extraction kit. The target gene was amplified using universal primers for the 16S rRNA gene and primers for the rpoB gene. The rpoB gene primer sequences are as follows: F: AAAAGGTTTTACCGCAACTG (SEQ ID NO: 1); R: CGCATCTTCTTCGTCTTCTA (SEQ ID NO: 2).

[0083] A 5 μL amplified product was run on a 1% agarose gel for electrophoresis and observed. Positive PCR products were sequenced. The resulting gene sequences were aligned to the GenBank database using Nucleotide BLAST. A phylogenetic tree was constructed using the neighbor-joining (NJ) method in MEGA 7.0 software. Boostrap was used for confidence testing, with 1000 runs of the self-checked dataset.

[0084] Sequencing results indicated that the 16s rRNA gene of strain BSY82 is approximately 1500 base pairs long. Alignment revealed that strain BSY82 shared the highest homology with Bacillus, with a similarity of 100%. PCR amplification of the rpoB gene sequence specific to strain BSY82 using rpoB primers revealed a 3500-base length rpoB gene sequence. The sequenced BSY82 gene was submitted to NCBI for homology analysis. Eleven highly homologous sequences were selected from the database for phylogenetic tree construction, as shown in Figures 7 and 8. Comparison revealed that strain BSY82 belongs to the same clade as Bacillus subtilis and shares the highest similarity with Bacillus inaquosorum 1HC-NA. Combined with bacterial morphology and physiological and biochemical characteristics, strain BSY82 was identified as Bacillus subtilis subsp. deserticola.

[0085] 4. Whole genome sequencing analysis of BSY82 strain

[0086] After the isolated strain BSY82 was cultured to the logarithmic growth phase, the bacteria were collected, the genomic DNA was extracted, and whole genome sequencing analysis was performed. The genome sequencing results showed that the whole genome sequence of the BSY82 strain was 4242094bp in length, with a G+C content of 44.02% and 4126 coding genes.

[0087] The resistance genes and virulence genes of strain BSY82 were predicted based on the Comprehensive Antibiotic Resistance Database (CARD) and the Virulence Gene Database (VFDB).

[0088] The prediction results for drug resistance and virulence genes (Tables 6 and 7) showed that strain BSY82 harbored three resistance genes, suggesting resistance to aminoglycosides. This finding contradicted the susceptibility test results, possibly due to gene non-expression or enzyme inactivation. Virulence gene prediction identified 19 potential virulence genes, all of which are intrinsic to the strain. No known virulence factors of Bacillus were predicted, including the diarrheal toxin-associated hemolysin BL gene (hblC), enterotoxin T gene (bceT), cytotoxin K gene (CytK), pleiotropic regulator (PlcR), and non-hemolytic enterotoxin (nheA). This demonstrates the high biosafety of strain BSY82.

[0089] The BglA gene was found from gene prediction. The gene sequence is 1440 bp long and encodes a protein containing 479 amino acids. The molecular weight of the protein is 54944.49 and the molecular formula is C 2479 H 3697 N 641 O 745 S 17 The amino acids with higher content in the protein are Glu (8.8%) and Gly (8.8%), and the amino acids with the lowest content are Pyl (0%) and Sec (0%). Among them, there are 76 acidic amino acids (Asp+Glu) and 47 basic amino acids (Arg+Lys). The isoelectric point is 4.81 and the instability index is 29.70. It is a stable protein.

[0090] The protein's hydrophilic region is larger than its aqueous region, indicating an overall hydrophilic nature (Figure 9). Signal peptide prediction results indicate the protein lacks a signal peptide (Figure 10), confirming that it is not secreted. Transmembrane region prediction results (Figure 11) indicate the protein lacks a transmembrane region, with all 479 amino acids located outside the membrane. The protein's tertiary structure prediction (Figure 12) indicates the peptide chain is primarily composed of α-helices.

[0091] The BglA gene encodes an arylphospho-β-D-glucosidase, and it is speculated that the BSY82 strain produces this enzyme to decompose glucosinolates in rapeseed meal.

[0092] Table 6 Predicted drug resistance genes of strain BS782

[0093] Table 7 Predicted virulence genes of strain BSY82

[0094] 5. Further verification of enzyme production capacity.

[0095] The enzyme activity assay utilizes the principle that myrosinase breaks down the substrate sinigrin (myrosinase potassium glucosidate) to produce glucose. First, the screened strain BSY82 was inoculated into LB liquid medium and cultured at 37°C, shaking at 180 rpm for 4 days. The fermentation broth was centrifuged and the supernatant was used as the crude enzyme solution. The standard curve for glucose content is shown in Figure 13.

[0096] Measure 200 μL of crude enzyme solution and 200 μL of 10 mg / mL sinigrin potassium glucosidate, incubate at 37°C in a water bath for 20 minutes, add 600 μL of colorimetric solution, boil for 2 minutes, and measure absorbance at 540 nm. One unit of enzyme activity is defined as the amount of enzyme required to catalyze the production of 1 μmol of product per minute at 30°C. Add 10 mL of crude glucosidase extract to 2 mL of crude enzyme solution and incubate in a shaker at 37°C, 180 rpm, for one hour. Measure the glucosidase degradation rate of the crude enzyme solution.

[0097] The experimental results show that using BSY82 strain fermentation liquid as a crude enzyme liquid, the substrate myrosinase potassium glucosidate (Sinigrin) is decomposed to generate glucose per unit time, and the enzyme activity is indirectly measured to be 1.67 μmol / min by comparing the glucose standard curve. One hour after the crude enzyme liquid was added to the glucosidase crude extract, the glucosidase content in the crude extract decreased by 68%. The myrosinase activity in the BSY82 strain fermentation liquid was analyzed using a high performance liquid chromatograph, and a myrosinase standard was used for reference comparison. The results showed that the myrosinase activity in the 24-hour fermentation liquid was 2.12 ± 0.068 U, and the fermentation liquid and the myrosinase standard had similar retention times on the chromatographic column. The myrosinase standard retention time is shown in Figure 14, and the fermentation liquid retention time is shown in Figure 15.

[0098] The technical features of the above-mentioned embodiments can be combined arbitrarily. In order to make the description concise, not all possible combinations of the technical features in the above-mentioned embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0099] The above-described embodiments merely illustrate several implementations of the present invention, and while their descriptions are relatively specific and detailed, they should not be construed as limiting the scope of the patent. It should be noted that a person skilled in the art would be able to make numerous variations and improvements without departing from the spirit of the present invention, all of which fall within the scope of protection of the present invention. Therefore, the scope of protection of the patent for this invention shall be determined by the appended claims.

Claims

1. A Bacillus subtilis, characterized in that The preservation number of the Bacillus subtilis is GDMCC No: 62938, and the preservation institution is Guangdong Provincial Microbiological Culture Collection Center.

2. The Bacillus subtilis according to claim 1, characterized in that The Bacillus subtilis secretes enzymes for decomposing glucosinolates.

3. The Bacillus subtilis according to claim 1, characterized in that The Bacillus subtilis secretes an enzyme for decomposing sinigrin potassium.

4. Use of the Bacillus subtilis according to any one of claims 1 to 3 in feed fermentation.

5. The use according to claim 4, characterized in that: The feed includes rapeseed meal.

6. Use of the Bacillus subtilis according to any one of claims 1 to 3 in the degradation of glucosinolates.

7. A feed, characterized in that: The invention comprises rapeseed meal after detoxification treatment, wherein the detoxification treatment comprises the following steps: fermenting the rapeseed meal with the Bacillus subtilis described in any one of claims 1 to 3.

8. A method for preparing a feed, characterized in that: The raw material of the feed includes rapeseed meal, and the preparation method of the feed includes the following steps: fermenting the rapeseed meal with the Bacillus subtilis described in any one of claims 1 to 3.

9. The method for breeding Bacillus subtilis according to any one of claims 1 to 3, characterized in that: The following steps are involved: Initial screening: culture the parent strain, select single colonies, purify and culture to obtain isolated strains, use glucosinolates for selective culture to obtain glucosinolate-utilizing strains, culture to the logarithmic growth phase, and screen to obtain strains without hemolytic rings; Rescreening: Add the strain without hemolytic ring to rapeseed meal, carry out solid-state fermentation, and screen out Bacillus subtilis.

10. The breeding method according to claim 8, characterized in that: The selective culture comprises: applying the isolated strain to a glucosinolate selective culture medium and culturing at 35-40° C. for 20-30 hours; The screening to obtain a strain without hemolytic ring comprises: inoculating the glucosinolate utilizing strain cultured to the logarithmic growth phase onto a blood plate, and culturing at 35-40° C. for 20-30 hours; The solid-state fermentation material-liquid ratio is (6-8):2, the solid-state fermentation temperature is 22-27°C, and the solid-state fermentation time is 45-50h.

Citation Information

Patent Citations

  • Bacillus subtilis and breeding method and application thereof

    CN117106627A

  • Bacillus subtilis CBN strain converting isoflavone glycoside to aglycone and direct-fed microorganisms comprising the same

    KR1020140140797A

  • Compositions and methods to increase production of isothiocyanates

    US20220193152A1

Cited By

  • Bacillus deserticola for resisting tobacco target leaf spot, bacterial drug compound agent and application of bacillus deserticola and bacterial drug compound agent

    CN120424833A